Depression and anxiety disorders are exploding in prevalence. It is believed that at least 3 million Australians, at any given time, suffer from these conditions. And, while we do have standard medication for many psychiatric and psychological conditions, research shows that anywhere between 60-90% of people prescribed antidepressants fail to get a benefit that is superior to placebo. What these statistics suggest is that we are not addressing the underlying causes.
Dr Mark Donohoe discusses the importance of gastrointestinal microbiome biodiversity for optimal health and wellbeing outcomes in our patients.
Professor Michael Holick, the world's leading expert on vitamin D research, responds to some of the more recent negative studies that seem to be so readily picked up by the media.
He then goes on to provide a roundup of some of the exciting, upcoming trials of this vitally important nutrient.